Medable AI Agent Promises $21M Value in Clinical Trials
October 8, 2026
Important Health - What Actually Matters
Health Policy
Peptides face metabolic stability challenges
October 9, 2026
Peptides face metabolic stability challenges in treating diseases like obesity and cardiovascular disorders with peptide therapeutics.
READ THE ARTICLE 
Cancer vaccine uses COVID immune memory
October 7, 2026
New Drug Survodutide Shows Promise for Obesity, Diabetes
October 5, 2026
RISK FACTORS
Cancer vaccine uses COVID immune memory
Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Apixaban Cuts Stroke Risk in Kidney Patients
Apixaban may cut stroke risk in kidney patients with atrial fibrillation and chronic kidney disease.
Vanderbilt informatics leader Peter Embí is named next NLM director, bringing decades of expertise in clinical research, AI,...
Virtual CKD management programs fail to slow disease progression or reduce costs, according to a Peterson Health Technology...
UNC researchers test doulas and alerts to improve Black maternal health outcomes in a major $10 million study...
Three healthcare programs use data to solve real problems in maternal, infant health and veteran care—proven innovations with...
All Post
Peptides face metabolic stability challenges
Peptides face metabolic stability challenges in treating diseases like obesity and cardiovascular disorders with peptide therapeutics.
Medable AI Agent Promises $21M Value in Clinical Trials
Medable's AI agent promises about $21M value in clinical trials, offering an 82x ROI for phase 3 studies.
Cancer vaccine uses COVID immune memory
Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Digital pathology enables virtual controls reduces animal testing
During the COVID-19 pandemic, the need for remote work pushed digital pathology from a niche tool to a core component...
New Drug Survodutide Shows Promise for Obesity, Diabetes
Survodutide shows promise as a treatment for obesity and diabetes, with significant weight loss and improved glycaemic control in trials.
Moving to Wealthier Areas Cuts Diabetes Risk
Research presented at the European Association for the Study of Diabetes meeting in Milan indicates that moving from a high-poverty...
South Goa Hospital Moves College Amid Bed Crunch
South Goa District Hospital is considering a temporary relocation of its nursing college to address critical space shortages for patients....
AI detects type 2 diabetes from short speech samples
Scientists report AI can detect type 2 diabetes from short speech samples at the European Association for the Study of...
Minimal Isometric Exercise Maintains Lower Blood Pressure
Isometric exercise training may help maintain lower blood pressure over the short term, providing a time-efficient option for those with...
Glenmark launches triple-action hypertension pill in India
Glenmark Pharmaceuticals has introduced Telma AM Biso , a fixed-dose combination tablet containing telmisartan, amlodipine, and bisoprolol for treating.